Literature DB >> 6696619

Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man.

M E Gottlieb, H H Stratton, J C Newell, D M Shah.   

Abstract

To evaluate hepatic function, the kinetics of indocyanine green clearance were studied in seven injured patients with hepatic venous catheters. Indocyanine green clearance after a bolus injection of 20 mg was relatively monoexponential on the first day after injury. Following this, a second slower compartment of indocyanine green clearance was uniformly evident, becoming most prominent around the fourth day after injury. Indocyanine green clearance again became more uniform as recovery continued. Fractional indocyanine green extraction ten minutes after injection decreased from 0.9 on the first day after injury to 0.2 three days later, and then returned to 0.7 on the seventh day after injury. These decreases in indocyanine green clearance preceded an increase in total serum bilirubin concentration to a mean value of 1.9 mg/dL. Indocyanine green clearance was thus found to be an early and sensitive indicator of impaired hepatic function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696619     DOI: 10.1001/archsurg.1984.01390150006002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  21 in total

1.  The indocyanine green test enables prediction of postoperative complications after hepatic resection.

Authors:  T Matsumata; T Kanematsu; Y Yoshida; T Furuta; K Yanaga; K Sugimachi
Journal:  World J Surg       Date:  1987-10       Impact factor: 3.352

2.  Dynamic contrast-enhanced optical imaging of in vivo organ function.

Authors:  Cyrus B Amoozegar; Tracy Wang; Matthew B Bouchard; Addason F H McCaslin; William S Blaner; Richard M Levenson; Elizabeth M C Hillman
Journal:  J Biomed Opt       Date:  2012-09       Impact factor: 3.170

3.  Adaptive trial of personalized radiotherapy for intrahepatic cancer.

Authors:  Daniel Normolle; Charlie Pan; Edgar Ben-Josef; Theodore Lawrence
Journal:  Per Med       Date:  2010       Impact factor: 2.512

Review 4.  Pharmacokinetics and pharmacodynamics in critically ill patients.

Authors:  H J Mann; D W Fuhs; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

5.  Profound reduction in morphine clearance and liver blood flow in shock.

Authors:  M S Macnab; D J Macrae; E Guy; I S Grant; J Feely
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

6.  Hepatic dysfunction during bacterial sepsis.

Authors:  A E Gimson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  Spatially resolved assessment of hepatic function using 99mTc-IDA SPECT.

Authors:  Hesheng Wang; Yue Cao
Journal:  Med Phys       Date:  2013-09       Impact factor: 4.071

8.  Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models.

Authors:  Matthew H Stenmark; Yue Cao; Hesheng Wang; Andrew Jackson; Edgar Ben-Josef; Randall K Ten Haken; Theodore S Lawrence; Mary Feng
Journal:  Radiother Oncol       Date:  2014-05-08       Impact factor: 6.280

9.  Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.

Authors:  Jeffrey M Vainshtein; Rafi Kabarriti; Keyur J Mehta; Jayanta Roy-Chowdhury; Chandan Guha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-15       Impact factor: 7.038

10.  Liver function after irradiation based on computed tomographic portal vein perfusion imaging.

Authors:  Yue Cao; Charlie Pan; James M Balter; Joel F Platt; Isaac R Francis; James A Knol; Daniel Normolle; Edgar Ben-Josef; Randall K Ten Haken; Theodore S Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-12       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.